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Abstract
Background: Campylobacter jejuni is a major cause of human gastroenteritis yet there is limited knowledge of
how disease is caused. Molecular genetic approaches are vital for research into the virulence mechanisms
of this important pathogen. Vectors that allow expression of genes in C. jejuni via recombination onto the
chromosome are particularly useful for genetic complementation of insertional knockout mutants and more
generally for expression of genes in particular C. jejuni host backgrounds.
Methods: A series of three vectors that allow integration of genes onto the C. jejuni chromosome were
constructed by standard cloning techniques with expression driven from three different strong promoters.
Following integration onto the C. jejuni chromosome expression levels were quantified by fluorescence
measurements and cells visualized by fluorescence microscopy.
Results: We have created plasmid, pCJC1, designed for recombination-mediated delivery of genes onto the C.
jejuni chromosome. This plasmid contains a chloramphenicol resistance cassette (cat) with upstream and
downstream restriction sites, flanked by regions of the C. jejuni pseudogene Cj0223. Cloning of genes immediately
upstream or downstream of the cat gene allows their subsequent introduction onto the C. jejuni chromosome within
the pseudogene. Gene expression can be driven from the native gene promoter if included, or alternatively from the
cat promoter if the gene is cloned downstream of, and in the same transcriptional orientation as cat. To provide
increased and variable expression of genes from the C. jejuni chromosome we modified pCJC1 through incorporation
of three relatively strong promoters from the porA, ureI and flaA genes of C. jejuni, Helicobacter pylori and Helicobacter
pullorum respectively. These promoters along with their associated ribosome binding sites were cloned upstream of
the cat gene on pCJC1 to create plasmids pCJC2, pCJC3 and pCJC4. To test their effectiveness, a green fluorescent
protein (gfp) reporter gene was inserted downstream of each of the three promoters and following integration of
promoter-gene fusions onto the C. jejuni host chromosome, expression levels were quantified. Expression from the
porA promoter produced the highest fluorescence, from flaA intermediate levels and from ureI the lowest. Expression
of gfp from the porA promoter enabled visualization by fluorescent microscopy of intracellular C. jejuni cells following
invasion of HeLa cells.
Conclusions: The plasmids constructed allow stable chromosomal expression of genes in C. jejuni and,
depending on the promoter used, different expression levels were obtained making these plasmids useful
tools for genetic complementation and high level expression.
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Background
Campylobacters, predominantly Campylobacter jejuni
and Campylobacter coli, are the most commonly re-
ported causal agents of zoonotic infection with an esti-
mated 400–500 million cases annually worldwide [1].
Campylobacteriosis is an acute, generally self-limiting,
diarrhoeal disease [2, 3] with a number of infrequent but
serious sequelae of infection including the peripheral
neuropathy Guillain-Barre syndrome. Due to its import-
ance as a human pathogen there are many research
groups employing molecular genetic approaches to in-
vestigate C. jejuni virulence and transmission. However,
the availability of tractable genetic tools is relatively lim-
ited and our knowledge of how C. jejuni causes disease
is thus also limited compared to other enteropathogens
such as Escherichia coli and Salmonella species.
One of the key methods for investigating C. jejuni gene
function is inactivation of specific genes through insertion
of antibiotic (generally kanamycin or chloramphenicol)
resistance cassettes via recombination-mediated allelic
replacement [4, 5]. To confirm associated phenotypes
such mutants are often genetically complemented with at
least partial restoration of phenotype confirming the spe-
cific role of the gene product under investigation. The two
approaches for complementation in C. jejuni are reintro-
duction of a functional gene either on a replicating plas-
mid [6, 7] or through chromosomal integration [8]. The
latter method involves construction of suicide plasmids
that allow recombination-driven introduction of func-
tional genes at specific loci on the C. jejuni chromosome.
These loci are chosen so as to minimise potential for un-
wanted effects of insertion and include intergenic region
of rRNA genes [8], or pseudogenes such as Cj0046 [9, 10]
and Cj0223 [11].
An important consideration when designing genetic
complementation strategies is the nature of the pro-
moter driving gene expression. Ideally one would use
the promoter region from which the gene is expressed
[10], but these are often difficult to identify accurately
and if the gene is part of an operon, may be located
some distance away potentially requiring further cloning
steps. A simpler and more commonly used strategy is to
use the promoter associated with the antibiotic resistance
cassette and insert the gene immediately downstream
without an intervening transcriptional terminator. How-
ever other more or less well characterized promoters from
C. jejuni such as that of the iron induced gene fdxA have
also been employed [12].
The aim of this study was to generate plasmids for in-
tegrating selected genes onto the C. jejuni chromosome
that allow expression at different levels. To this end we
employed one of three distinct Campylobacter or Helico-
bacter promoter regions to drive gene expression. Using
these plasmids to introduce reporter gene gfp onto the
C. jejuni NCTC 11168 chromosome we measured three
significantly different levels of gene expression. The
highest of these enabled us for the first time to readily
visualize intracellular fluorescent C. jejuni cells express-
ing chromosomal gfp during in vitro cell invasion experi-
ments using a standard fluorescent microscope. The use
of these plasmids to generate stable highly fluorescent C.
jejuni strains should have widespread applications and
improve our knowledge of the virulence and transmis-
sion of this major pathogen. These plasmids will also be
useful for both genetic complementation and more gen-
erally for expressing genes of other origin in C. jejuni
backgrounds.
Methods
Bacterial strains
Escherichia coli XL10 gold strains (Stratagene) were
grown in Luria-Bertani (LB) broth or on LB agar plates. C.
jejuni NCTC 11168 and H. pullorum NCTC 12824 strains
from the UK National Collection of Type Cultures were
grown on Columbia agar containing 5 % defibrinated
horse blood (TCS Biosciences) at 42 °C in a modified
atmosphere (85 % N2, 10 % CO2, and 5 % O2) generated
with a VA500 workstation (Don Whitley Ltd.). Chloram-
phenicol was used at a concentration of 17 μg/ml for E.
coli and 34 μg/ml for Campylobacter. Ampicillin was used
at a concentration of 100 μg/ml.
Construction of C. jejuni expression vectors
The promoter regions of the C. jejuni NCTC 11168
porA, H. pullorum NCTC 12824 flaA and H. pylori
26695 ureI, genes were amplified with primer pairs
porAXhoI-F/R, flaAXhoI-F/R and ureIXhoI-F/R respect-
ively (Table 1), and cloned into the XhoI site immedi-
ately upstream of the cat cassette of pCJC1. A variant of
the highly fluorescent gfp + gene [13] known as gfpTCD
[14] was amplified using primer pair gfp-F/R (Table 1)
and cloned into the NdeI site created in the promoter
regions. The codon-optimised gfpCj based on gfpTCD was
synthesized (Eurofins) with flanking NdeI sites.
Transformation of C. jejuni
Electrocompetent C. jejuni cells were prepared and trans-
formed with plasmid DNA using standard protocols [15].
GFP fluorescence monitoring of Campylobacter cultures
Cultures of C. jejuni were grown on blood agar for 24 h,
resuspended in Heart Infusion (HI) broth and used to
inoculate 2 ml HI broth supplemented with 5 % bovine
foetal serum (BFS) to an OD600 of 0.05. Cultures were
grown in a 6-well tissue culture dish in a modified at-
mosphere (as above) for approximately 16 h at 42 °C
with shaking at 125 rpm. When cultures reached mid-
log phase (between OD600 0.2 and 0.4) they were
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harvested by centrifugation, washed in PBS and resus-
pended to an OD600 of 1.0. A 10-fold dilution series
of the bacterial suspension was made and 180 μl
added in triplicate to a black-walled 96-well plate
with transparent base. Both OD600 and fluorescence
(excitation at 485/20 nm and emission at 528/20 nm)
were measured on a Bio-Tek Synergy HT plate
reader. Fluorescence in arbitrary units (AU) was cal-
culated by dividing the Relative Fluorescence Units
(RFU) by the corresponding OD600 value.
Immunodetection of recombinant proteins
C. jejuni strains expressing GFP were grown as for fluor-
escence measurement described above and whole cell
lysates prepared after normalizing by OD600. Western
blots were performed using mouse anti-GFP antibody
(Sigma) and goat anti-mouse secondary antibody (Li-Cor).
Preparation of C. jejuni for fluorescence microscopy
C. jejuni strains expressing GFP were grown as above
and approximately 108 cells were washed in 1 ml of
phosphate buffered saline (PBS) and resuspended in
50 μl of PBS. Approximately 10 μl of this suspension
was spread on a glass slide, dried, heat fixed and 50 μl of
1 μg/ml 4′,6-diamidino-2-phenylindole (DAPI) added.
Following incubation at room temperature for 20 min,
slides were washed three times in PBS. Glass coverslips
were adhered using Mowiol 4–88 and left to dry before
imaging (see below).
HeLa cell infection by C. jejuni
HeLa cells cultured in Dulbecco’s Modified Eagles
Medium (DMEM) were seeded into 6-well plates con-
taining glass coverslips at 1.5 x 105 cells per well, and in-
cubated for 24 h at 37 °C with 5 % CO2, to obtain a final
density of 5 x 105 cells per well. Cells were washed with
Dulbecco’s Phosphate Buffered Saline (PBSD) twice be-
fore infection. Mid-log cultures of C. jejuni grown in HI
broth supplemented with 5 % BFS were harvested,
washed twice in 1 ml PBS and added to HeLa cell cul-
tures at a multiplicity of infection (MOI) of 10. Plates
were incubated for a further 2 h, washed three times
with PBSD and serum-free medium containing 50 μg/ml
gentamicin added. After 1 h cover slips were removed,
incubated in PBS containing 3 % paraformaldehyde for
20 min at room temperature and washed three times in
PBS, the last wash containing 10 mM glycine (pH 8.5).
Coverslips were then incubated in PBS containing 0.1 %
Triton X-100 for 4 min at room temperature, washed
three times in PBS, stained with DAPI as above and with
the fluorescent actin stain phalloidin-Atto590 (Sigma) at
1:400 dilution followed by three final PBS washes.
Fluorescence microscopy of C. jejuni and HeLa cells
Images were collected on an Olympus BX51 upright
microscope using a 40x/ 0.75 Plan Fln or 60x/ 0.65-1.25
Plan Fln objective and captured using a Coolsnap EZ cam-
era (Photometrics) through MetaVue Software (Molecular
Devices). Specific band pass filter sets for DAPI, FITC and
Texas Red were used for visualizing DAPI, GFP and
phalloidin-Atto590, respectively. Images were processed
and analysed using ImageJ (http://rsb.info.nih.gov/ij).
Results
Design of novel C. jejuni chromosomal expression
systems
We have previously used a vector for genetic comple-
mentation in C. jejuni consisting of a 2179 bp fragment
(corresponding to nt 205297–207475 inclusive of the C.
jejuni NCTC 11168 genome sequence) cloned into
pUC18 with a chloramphenicol resistance (cat) cassette
cloned into a central SpeI site [11]. The cat gene is thus
flanked by regions from pseudogene Cj0223, so that
electroporation of this vector into C. jejuni cells results
in integration, through a double recombination event, of
the cat cassette and gene-of-interest onto the chromo-
some within Cj0223. This vector was modified by intro-
duction of BglII/XhoI and NcoI/NheI sites flanking the
cat cassette to produce plasmid pDENNIS [16]. This
facilitated insertion of genes either upstream or down-
stream of cat and was used successfully for genetic com-
plementation in C. jejuni [16]. We have now renamed
Table 1 Primers used in this study
Primer Sequencea (5′- > 3′)
porAXhoI-F CAA GAA CTC GAG CTT AAA ATT ACA CGC CTA GC
porAXhoI-R AAT TCA CTC GAG CAT ATG AAT TCT CCT TGT CAA AAA TTA
flaAXhoI-F CAA GAA AAG CTT GCT ATC AAA AAT TAA AAT GAT TGT C
flaAXhoI-R AAT TCA AAG CTT CAT ATG AAA CTC CTT TAT ATT GCC TC
ureIXhoI-F CAA GAA AAG CTT CCT TAA ATC CTT AGT TTT TAG C
ureIXhoI-R AAT TCA AAG CTT CAT ATG CTT TTC CTT CCA AAC AAA AAT T
gfp-F AGA ACC CAT ATG AGC AAA GGC GAA GAG CTG
gfp-R AAA CTC CAT ATG TTA CTT ATA CAG TTC ATC CAT ACC
aRestriction sites underlined
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BglIISpeI XhoI NheINcoI SpeI
Cj0223 Cj0223cat
XhoI XhoINdeI
SD
BglIISpeI XhoI NheINcoI SpeI
Cj0223 Cj0223cat
PureI
XhoI XhoINdeI
SD
PflaA
XhoI XhoINdeI
SD
PporA
XhoINdeI
SD
PureI
BglIISpeI XhoI NheINcoI SpeI
Cj0223 Cj0223cat
XhoINdeI
SD
PflaA
BglIISpeI XhoI NheINcoI SpeI
Cj0223 Cj0223cat
XhoINdeI
SD
PporA
gfp
NdeINdeI
BglIISpeI XhoI NheINcoI SpeI
Cj0223 Cj0223cat
XhoI
NdeI
SD
PureI
gfp
NdeI
BglIISpeI XhoI NheINcoI SpeI
Cj0223 Cj0223cat
XhoI
NdeI
SD
PflaA
gfp
NdeI
BglIISpeI XhoI NheINcoI SpeI
Cj0223 Cj0223cat
XhoI
NdeI
SD
PporA
gfp
NdeI
pCJC2
pCJC3
pCJC4
pCJC2gfp
pCJC3gfp
pCJC4gfp
pCJC1
Fig. 1 (See legend on next page.)
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pDENNIS as pCJC1 (Fig. 1). To further develop this vec-
tor providing increased and more flexible expression
levels of genes introduced onto the C. jejuni chromo-
some, we have modified pCJC1 by cloning three distinct
promoter regions, including native Shine-Dalgarno (SD)
sequences and associated start codons (Fig. 2) immedi-
ately upstream of the cat gene (Fig. 1). Promoter regions
(described below) were selected from Campylobacter
and Helicobacter species based on previous evidence of
their relatively high activity.
The first, (PporA), is from the C. jejuni NCTC 11168
porA gene. Under several different growth conditions
porA transcript is one of the most abundant in the tran-
scriptome [17, 18]. Although transcription from PporA
has been studied [19, 20], the promoter has not been
mapped in detail. Our in silico analysis of the porA up-
stream region identified a putative SD site and a σ70-type
promoter approximately 170 bp upstream of the start
codon (Fig. 2). The second σ70-type promoter region
chosen, PureI from the H. pylori ureI gene (Fig. 2), was
previously used in a plasmid-based inducible expression
system for H. pylori [21]. The third promoter (PflaA) is
from the Helicobacter pullorum NCTC 12824 flaA gene
(Fig. 2), a species studied in our laboratory. The flaA
σ28-dependent promoters from C. jejuni [22] and H. pyl-
ori [23] are well characterized. A σ28 type promoter and
SD site were identified upstream of H. pullorum flaA
although the putative −10 and −35 regions are signifi-
cantly further upstream (154 bp) compared to those
from C. jejuni (54 bp) and H. pylori (57 bp) (Additional
file 1: Figure S1).
Each promoter region with cognate SD site and ATG
start site was PCR amplified to include 5′ and 3′ XhoI
restriction sites allowing insertion into the unique XhoI
site upstream of the pCJC1 cat cassette (Fig. 1). Primers
were designed so that an NdeI site was placed adjacent
to the XhoI site located immediately upstream of the cat
cassette (Fig. 1). The NdeI recognition sequence of
CA*TATG and primer design was such that the three
bases preceding the start codon were altered to CAT to
create the NdeI site (Fig. 2). This potentially allows
introduction of a gene at the NdeI site creating a
Fig. 2 Promoter regions employed in this study. The H. pylori 26695 ureI promoter region is previously characterised, the C. jejuni 11168 porA and
H. pullorum NCTC 12824 flaA promoters are putative based on known consensus sequences. Boxed sequences denote known or putative −10
and −35 regions with the start codon of the associated open reading frames in bold capitals. Sequences were amplified by PCR to include 5′ and
3′ restriction sites and italicised bases were altered to “CAT” to create an NdeI site at the 3′ end
(See figure on previous page.)
Fig. 1 Construction of expression vectors for integration onto the C. jejuni chromosome. Construction of the pCJC series of plasmids for integration
in the C. jejuni 11168 pseudogene Cj0223. A fragment of Cj0223 cloned into pUC18 is interrupted by a chloramphenicol resistance cassette (cat) at a
unique SpeI site. Promoter regions with Shine-Dalgarno (SD) sites were cloned into the XhoI site followed by insertion of gfp at the NdeI site. Three
promoter regions were used: H. pylori ureI to create pCJC2, H. pullorum flaA to create pCJC3 and C. jejuni porA to create pCJC4
Jervis et al. BMC Microbiology  (2015) 15:230 Page 5 of 9
translational fusion to the start codon without altering
the spacing between SD and start codon. Plasmids con-
structed in this way containing the PureI, PflaA and PporA
promoters were named pCJC2, pCJC3 and pCJC4
respectively (Fig. 1).
Analysis of relative expression levels in Campylobacter
jejuni 11168
To test the relative expression levels from each of the pro-
moter regions in C. jejuni we commercially synthesised
a C. jejuni codon-optimised version of the gfp + gene
[13, 23] and this was named gfpCj (Additional file 2: Figure
S2, GenBank accession KP994992). The gfpCj gene was
PCR amplified with 5′ and 3′ NdeI sites using primers
gfp-F and gfp-R (Table 1) and inserted into pCJC2, pCJC3
and pCJC4 in the same transcriptional orientation as the
cat gene, creating plasmids pCJC2gfpCj, pCJC3gfpCj and
pCJC4gfpCj respectively (Fig. 1). These C. jejuni suicide
vectors were electroporated into strain 11168 and trans-
formants identified in which a double recombination
event had occurred at the Cj0223 locus. Strains con-
structed in this way were termed 11168gfp2, 11168gfp3
and 11168gfp4 and no significant effect on growth com-
pared to the parental strain was observed (data not
shown). To investigate promoter strength, relative fluores-
cence of early/mid-exponential phase cells of C. jejuni
NCTC 11168 and the three gfpCj expressing strains was
measured in a 96-well plate reader (see Methods).
All three strains (11168gfp2, 11168gfp3 and 11168gfp4)
displayed significantly higher fluorescence than wild-type
11168 cells. The levels of fluorescence from 11168gfp2,
11168gfp3 and 11168gfp4 were 106.0 (+/− 2.1 SE), 197.6
(+/− 23.1 SE) and 4002.9 (+/− 252.5 SE) arbitrary fluores-
cence units /OD600 respectively reflecting activity of their
corresponding promoters PureI, PflaA and PporA. Parallel
Western blotting experiments of standardized whole-cell
lysates from 11168gfp2, 11168gfp3 and 11168gfp4 using
an anti-GFP antibody confirmed the gfp expression level
pattern of PureI < PflaA < PporA (Fig. 3). The varying expres-
sion levels of these three promoter regions will allow a
choice of promoter for recombinant gene expression in C.
jejuni based upon the desired application.
Cultures of the C. jejuni 11168gfp4 strain with the
PporA promoter driving expression of gfp
Cj displayed very
high fluorescence levels and so we tested its utility for in
vitro imaging. Broth-grown cultures of 11168gfp4 were
stained with DAPI and visualised for DAPI and GFP
fluorescence by standard fluorescence microscopy (see
Methods). Cells were clearly visible by GFP fluorescence
(Fig. 4a) and fluorescence levels appeared consistent
across individual cells as judged by comparison with
DAPI staining, indicating homogenous levels of GFP
production in the population, important for in vitro and
in vivo experiments. We therefore used strain C. jejuni
11168gfp4 to infect HeLa cells in a basic cell invasion
assay to determine if fluorescence levels were sufficient
to monitor intracellular C. jejuni. Mid-log phase C.
jejuni grown in broth were used to infect 24 h HeLa
cells with an MOI of 10 prior to treatment with genta-
micin to kill extracellular bacteria. Fixed HeLa cells were
viewed by fluorescence microscopy following staining of
cellular actin. Highly fluorescent intracellular C. jejuni
cells were readily visualized within the actin and DAPI-
stained HeLa cells (Fig. 4b). These observations confirm
the utility of the combination of high activity promoter
with insertion onto the C. jejuni chromosome to pro-
duce strains that stably express genes at high level. .
Discussion
Genetic tools for the expression of recombinant genes
are important for a number of applications and the lack
of such tools for C. jejuni has been a limiting factor in
experimental design. Here we have described a flexible
set of constructs for the stable expression of genes at
relatively low, medium and very high levels after
chromosomal integration downstream of three distinct
promoters. These expression levels can be used for
applications such as functional complementation when
low/medium expression levels might be desired and for
the production and purification of specific proteins
employing higher expression levels. The utility of very
high-level expression from the PporA promoter was dem-
onstrated by creating the highly fluorescent C. jejuni
11168gfp4 strain. The constructs described (pCJCgfp2,
pCJCgfp3 and pCJCgfp4) could also be used to produce
gfp translational fusions for determining the cellular
localisation of specific proteins.
We have used a method for integrating genes onto the
C. jejuni chromosome that targets pseudogene Cj0223 to
minimize potential for a deleterious effect on cells.
Cj0223 contains multiple frame-shift mutations/in-frame
stop codons and is therefore non-functional and has
been previously used to insert genes onto the C. jejuni
chromosome [11]. The Cj0223 pseudogene is also
present in most commonly used strains of C. jejuni so
that this approach should be generally applicable.
Fig. 3 GFP levels from single copy chromosomal gfpCj in C. jejuni
strains 11168gfp2, 11168gfp3 and 11168gfp4. GFP detected by
Western blotting in whole-cell lysates from strains 11168gfp2 (ureI),
11168gfp3 (flaA) and 11168gfp4 (porA)
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The promoter elements used in this study were chosen
based on previous studies describing either their activity
or their utility in similar expression systems. The C.
jejuni porA promoter is one of the strongest constitutive
promoters in recent RNA-seq transcriptome studies, and
PorA is the dominant protein in SDS-PAGE of C. jejuni
whole-cell lysates [17, 18]. Promoter PflaA from H. pull-
orum was used as high levels of FlaA protein are pro-
duced in both C. jejuni and H. pylori. Promoter PureI
from H. pylori is a constitutive promoter successfully
used in a H. pylori plasmid-based inducible expression
system [21, 24]. To measure activity of these promoters
we employed GFP as a reporter. Codon optimization of
gfp for expression in C. jejuni more than doubled fluor-
escence observed with the PporA promoter (data not
shown) highlighting the importance of considering spe-
cific translational features of host background. Indeed
this gfpCj allele might be considered for more general
Fig. 4 Fluorescent microscopy of C. jejuni 11168gfp4 cells. a. Fluorescent imaging of cells of wild-type C. jejuni NCTC 11168 and the 11168gfp4 strain
expressing chromosomal gfpCj driven by the C. jejuni promoter PporA. b. Fluorescent imaging of gentamicin-treated HeLa cells, 3 h post-infection with
C. jejuni NCTC 11168gfp4 expressing chromosomal gfpCj driven by the C. jejuni promoter PporA. Cells were stained with DAPI (blue) and phalloidin (red)
with GFP fluorescence in green
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use in C. jejuni for applications such as a reporter gene for
transcriptional and translational analysis and as a fusion
partner for protein localization and quantitation. Com-
parison of fluorescence levels for strains expressing gfp
from PureI, PflaA and PporA demonstrated an approximately
doubling of fluorescence with PflaA compared to PureI and
a further approximately twenty-fold increase with PporA.
We propose that PporA should be the promoter of choice
when high-level expression of recombinant proteins is
desired although potential toxicity issues should be con-
sidered. The high level expression from PporA is also very
useful for protein purification. High level expression of
genes to produce specific proteins for structural/func-
tional characterisation is generally performed in E. coli as
this allows rapid and inexpensive production of large
amounts of biomass and hence protein. However in
certain circumstances where proteins may be post-
translationally modified, for example by the protein glyco-
sylation systems found in Campylobacters and some
Helicobacter species, then production in these particular
species is required to produce appropriately modified pro-
teins. We successfully used promoter PporA to drive
expression of hgpA encoding an N-linked glycoprotein in
H. pullorum with sufficient yields for purification of milli-
grams of HgpA glycoprotein (data not shown).
In summary, the vectors presented in this work pro-
vide a useful set of tools to aid in molecular studies of
this important bacterial pathogen and the principles in-
volved in designing these tools should be generally ap-
plicable to other bacteria. Additionally we have
constructed a new gfp allele that in combination with
the expression systems described produced a highly
fluorescent C. jejuni strain expressing gfpCj from the
chromosome for potential use in both in vitro and in
vivo infection studies. The advent of synthetic biology
and the affordable technology of gene synthesis will
facilitate further development of these and other systems
to produce a valuable genetic toolbox to aid in Campylo-
bacter and Helicobacter research.
Conclusions
We have constructed vectors allowing recombination-
mediated incorporation of genes onto the C. jejuni
chromosome downstream of one of three promoters
with varying expression levels. These vectors will be use-
ful for genetic complementation, expression of genes at
relatively high levels and construction of GFP transla-
tional fusions in this important bacterial pathogen.
Additional files
Additional file 1: Figure S1. Sigma 28-dependent promoters of flaA
genes from C. jejuni NCTC 11168, H. pylori 26695 and H. pullorum NCTC
12824. C. jejuni and H. pylori promoters are characterized [22, 23] and the
putative promoter for H. pullorum is uncharacterized. Boxed sequences
denote -10 and -35 regions, text in bold uppercase the flaA open reading
frame start codon, text in bold the transcriptional start site and text in
bold and italics the Shine-Dalgarno sequences. (DOCX 135 kb)
Additional file 2: Figure S2. Nucleotide sequence of the C. jejuni
codon-optimised gfp gene (gfpCj). (DOCX 19 kb)
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